158 related articles for article (PubMed ID: 3603365)
1. Optimization of cancer radiotherapy with selective sensitizers.
Wideröe R
Strahlenther Onkol; 1987 Jun; 163(6):378-84. PubMed ID: 3603365
[TBL] [Abstract][Full Text] [Related]
2. [Radiation sensitizers: with special reference to hypoxic cell sensitizers].
Onoyama Y; Nakajima T; Tanaka M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):894-903. PubMed ID: 3963856
[TBL] [Abstract][Full Text] [Related]
3. [Electron acceptor compounds as radiation sensitizers of hypoxic cells in human tumors].
Kiseleva ES; Dar'ialova SL
Med Radiol (Mosk); 1984 Sep; 29(9):74-82. PubMed ID: 6384719
[No Abstract] [Full Text] [Related]
4. Hypoxic sensitizers--implications for radiation therapy.
Chapman JD
N Engl J Med; 1979 Dec; 301(26):1429-32. PubMed ID: 229413
[No Abstract] [Full Text] [Related]
5. [Radiosensitization research in cancer therapy].
Sugahara T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):405-11. PubMed ID: 3890755
[TBL] [Abstract][Full Text] [Related]
6. Role of hypoxic sensitizers in radiotherapy.
Singh DR; Krishnan D
Indian J Cancer; 1981 Mar; 18(1):63-8. PubMed ID: 7262909
[No Abstract] [Full Text] [Related]
7. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
8. [Role of radiation biology in the standardization and optimization of radiotherapy].
Onoyama Y
Gan No Rinsho; 1985 Sep; 31(12):1525-8. PubMed ID: 4079041
[TBL] [Abstract][Full Text] [Related]
9. A small prospective study of chordomas treated with radiotherapy and razoxane.
Rhomberg W; Böhler FK; Novak H; Dertinger S; Breitfellner G
Strahlenther Onkol; 2003 Apr; 179(4):249-53. PubMed ID: 12707714
[TBL] [Abstract][Full Text] [Related]
10. The role of radiosensitizing drugs in the management of cancer.
Adams GE
Invest Cell Pathol; 1979; 2(4):303-8. PubMed ID: 396284
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
el-Said A; Menke D; Dorie MJ; Brown JM
Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
[TBL] [Abstract][Full Text] [Related]
12. [Enhancement of the antitumor effect of ionizing radiations in the combined use of metronidazole and induced hyperglycemia].
Vinskaia NP; Voloshina EA; Vygodskaia AL; Iarmonenko SP
Med Radiol (Mosk); 1984 Dec; 29(12):13-7. PubMed ID: 6513744
[TBL] [Abstract][Full Text] [Related]
13. [Modification of the radiation effects for overcoming radiation-resistant hypoxic tumor tissue].
Moldenhauer H; Rose H; Saul G; Wolf G; Kehrberg G
Radiobiol Radiother (Berl); 1983; 24(5):597-614. PubMed ID: 6316407
[No Abstract] [Full Text] [Related]
14. Hypoxic cell sensitizers and heavy charged particle beams may play complementary roles in killing hypoxic tumor cells.
Curtis SB; Tenforde TS; Afzal SM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1203-5. PubMed ID: 6432747
[TBL] [Abstract][Full Text] [Related]
15. [Enhancement of hyperthermochemotherapy with hypoxic cell radiosensitizers].
Ohta M; Fujimoto S; Shresta RD; Kokubun M; Kobayashi K; Kiuchi S; Miyoshi T; Arimatsu N; Mori T; Okui K
Gan No Rinsho; 1988 Mar; 34(3):283-7. PubMed ID: 3128668
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitizers: rationale and potential.
Brown JM
Cancer Treat Rep; 1981; 65 Suppl 2():95-102. PubMed ID: 7346152
[TBL] [Abstract][Full Text] [Related]
17. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmaceuticals (Strontium 89) and radiosensitizers (idoxuridine).
Otto SE
J Intraven Nurs; 1998; 21(6):335-7. PubMed ID: 10392098
[TBL] [Abstract][Full Text] [Related]
19. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for malignant hemangioendotheliomas of the thyroid.
Rhomberg W; Boehler F; Eiter H; Fritzsche H; Breitfellner G
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):401-5. PubMed ID: 15380572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
